Status:
COMPLETED
Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly Patients
Lead Sponsor:
Campus Bio-Medico University
Collaborating Sponsors:
IRCCS San Raffaele
DSM Nutritional Products, Inc.
Conditions:
Arrhythmia
Eligibility:
All Genders
65+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to test the hypothesis that dietary supplementation with an algal source of docosahexaenoic acid (DHA) can improve the heart rate variability in elderly patients.
Detailed Description
In western countries, sudden cardiac death (SCD) represents the most common form of cardiovascular death. SCD is often caused by ventricular arrhythmias in patients with a known history of ischemic he...
Eligibility Criteria
Inclusion
- Age above 65 years
Exclusion
- Treatment with or allergy to polyunsaturated fatty acids
- Diagnosis of arrhythmia or antiarrhythmic therapy
- Anticoagulant therapy (except acetylsalicylic acid)
- Pacemaker
- Bleeding diathesis
- Recent cerebral hemorrhage (less than 6 months)
- Thyroid dysfunction
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00749307
Start Date
June 1 2008
End Date
November 1 2009
Last Update
November 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele Pisana. Department of Medical Sciences. Cardiovascular Research Unit.
Rome, RM, Italy, 00163